Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy
about
Cell biology of disease: Telomeropathies: an emerging spectrum disorderGenomic characterization of the inherited bone marrow failure syndromes.Dyskeratosis congenita caused by a novel TERT point mutation in siblings with pancytopenia and exudative retinopathy.Bone marrow morphology and disease progression in congenital thrombocytopenia: a detailed clinicopathologic and genetic study of eight cases.Transcriptional analysis of apoptotic cerebellar granule neurons following rescue by gastric inhibitory polypeptideTelomere biology and translational research.The diagnosis and treatment of dyskeratosis congenita: a review.Telomere maintenance mechanisms in cancer: clinical implicationsClonal hematopoiesis, with and without candidate driver mutations, is common in the elderly.Potential relationship between inadequate response to DNA damage and development of myelodysplastic syndrome.Association between regulator of telomere elongation helicase 1 polymorphism and susceptibility to glioma.TeloPIN: a database of telomeric proteins interaction network in mammalian cellsTelomere length variation: A potential new telomere biomarker for lung cancer risk.Poly(A)-specific ribonuclease deficiency impacts telomere biology and causes dyskeratosis congenita.mRNA deadenylation and telomere disease.Identification of Genes That Modulate Susceptibility to Formaldehyde and Imatinib by Functional Genomic Screening in Human Haploid KBM7 Cells.Clinical utility gene card for: Dyskeratosis congenita - update 2015.Marked overlap of four genetic syndromes with dyskeratosis congenita confounds clinical diagnosisNature vs nurture: interplay between the genetic control of telomere length and environmental factors.Clinical outcomes of lung transplant recipients with telomerase mutations.Biology of telomeres: lessons from budding yeast.Telomerase promoter mutations in cancer: an emerging molecular biomarker?Understanding chronic neutropenia: life is short.Involvement of Atm and Trp53 in neural cell loss due to Terf2 inactivation during mouse brain developmentComparison of different methods for telomere length measurement in whole blood and blood cell subsets: Recommendations for telomere length measurement in hematological diseases.Reverse Expression of Aging-Associated Molecules through Transfection of miRNAs to Aged Mice.Genome-wide studies of telomere biology in budding yeastFamilial Myelodysplastic/Acute Leukemia Syndromes-Myeloid Neoplasms with Germline PredispositionRetinal findings and a novel TINF2 mutation in Revesz syndrome: Clinical and molecular correlations with pediatric retinal vasculopathies.Effects of TIN2 on telomeres and chromosomes in the human gastric epithelial cell line GES-1.
P2860
Q28385689-5F55B623-6E75-426B-B279-DAFD31AF44FCQ33411559-250238B7-CE18-443F-AFA3-931D85D5E959Q33416762-FB249009-8C43-43C9-98CC-227BF37F5166Q33438202-C7A90956-A3B5-411C-839B-DDC392E54131Q33580451-CC714BC0-2DD6-45B5-9676-2EA3CB54D1DAQ33613946-9C616F39-7FBD-4F9F-BDAB-96A921D8BFCCQ34094121-19717F5E-9880-421A-8582-F2AF600ADE54Q34426966-A1A6F109-06B6-4614-9C17-B8B308B5481CQ34556382-CB1A3295-693C-4FCF-9C93-D1929BBE4096Q35016534-F1517D9B-175D-4D79-8567-C13A1B672B69Q35173578-D1DD58C4-C801-4966-93B6-490B2510E855Q35193008-574561A5-D2DD-4C8B-9948-7181B17CBFE3Q35598049-3D0C9D0F-ED39-4C7A-863D-630DE0EC1FC8Q35719990-813F657D-A6B3-4013-B4E3-1719F6FECB1CQ35720144-40D868D0-C3F1-4002-BA7E-1A6063EA2096Q35968059-D7568298-D460-450A-8448-5B8B37BEC822Q36341025-D1E07934-788A-4F5E-9BCB-5C42EEA656AEQ37304109-46D42851-8D0E-44C1-B823-AC83A80248E5Q37530242-5AB37FFB-4062-4353-A2BD-936D8098D193Q37739710-A421B5D3-F5A7-44A8-92B0-FB6A36315D9BQ38206208-18206A61-1A4E-4694-AA71-B4F033DF9C20Q38232447-EAFA174E-924F-4305-9A68-E23DB68D8DD6Q38604646-8F9CD86E-8C99-4E25-B1D5-4F344C0BD357Q38722958-C4E931AF-D56A-4708-91CC-1CA8F726D335Q38736924-78F3FAAD-83E7-4AAB-90B1-8AC7407E5D43Q38889012-3E10FC9C-3FC6-4205-B8E5-D090598B3272Q39208015-E05743C7-1D99-4649-BF51-5CA0C3AE20DDQ41684390-4BB0CC26-1CDB-43D1-BC69-E6E0024ECF4CQ47341406-F7A9C8CE-D08D-47F3-90AE-32CD8E9CB93CQ52649725-75C17A79-7F87-4098-85C2-68FFA6237C17
P2860
Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy
@ast
Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy
@en
Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy
@nl
type
label
Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy
@ast
Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy
@en
Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy
@nl
prefLabel
Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy
@ast
Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy
@en
Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy
@nl
P2860
P1476
Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy
@en
P2093
Alison A. Bertuch
Maria M. Gramatges
P2860
P304
P356
10.1016/J.TRSL.2013.05.003
P407
P577
2013-12-01T00:00:00Z